6.
Bruu A, Hjetland R, Holter E, Mortensen L, Natas O, Petterson W
. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol. 2000; 7(3):451-6.
PMC: 95893.
DOI: 10.1128/CDLI.7.3.451-456.2000.
View
7.
Tsaparas Y, Brigden M, Mathias R, Thomas E, Raboud J, Doyle P
. Proportion positive for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, Toxoplasma, and human immunodeficiency virus types 1 and 2 in heterophile-negative patients with an absolute lymphocytosis or an instrument-generated atypical.... Arch Pathol Lab Med. 2000; 124(9):1324-30.
DOI: 10.5858/2000-124-1324-PPFEBV.
View
8.
Vigue M, Tuaillon E, Makinson A, Bullen G, Foulongne V, Segondy M
. Lymphoma-Like Syndrome: 4 Case Reports About Atypical Presentation of Primary Cytomegalovirus Infection in Immunocompetent Children. Medicine (Baltimore). 2015; 94(26):e855.
PMC: 4504613.
DOI: 10.1097/MD.0000000000000855.
View
9.
Evans A, Niederman J, Cenabre L, West B, Richards V
. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975; 132(5):546-54.
DOI: 10.1093/infdis/132.5.546.
View
10.
HOAGLAND R
. RESURGENT HETEROPHIL-ANTIBODY REACTION AFTER MONONUCLEOSIS. N Engl J Med. 1963; 269:1307-8.
DOI: 10.1056/NEJM196312122692409.
View
11.
Dommerby H, Stangerup S, Stangerup M, Hancke S
. Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasonic scanning. J Laryngol Otol. 1986; 100(5):573-9.
DOI: 10.1017/s0022215100099680.
View
12.
Horwitz C, Henle W, Henle G, Schapiro R, Borken S, Bundtzen R
. Infectious mononucleosis in patients aged 40 to 72 years: report of 27 cases, including 3 without heterophil-antibody responses. Medicine (Baltimore). 1983; 62(4):256-62.
DOI: 10.1097/00005792-198307000-00005.
View
13.
Balfour Jr H, Odumade O, Schmeling D, Mullan B, Ed J, Knight J
. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis. 2012; 207(1):80-8.
PMC: 3523797.
DOI: 10.1093/infdis/jis646.
View
14.
Gulley M
. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn. 2001; 3(1):1-10.
PMC: 1907346.
DOI: 10.1016/S1525-1578(10)60642-3.
View
15.
Lupo J, Tsougaev M, Blachier S, Chovelon G, Truffot A, Leroy C
. Comparison of Elecsys and Liaison immunoassays to determine Epstein-Barr virus serological status using further diagnostic approaches to clarify discrepant results. J Med Virol. 2022; 95(1):e28166.
PMC: 10092878.
DOI: 10.1002/jmv.28166.
View
16.
Svahn A, Magnusson M, Jagdahl L, Schloss L, Kahlmeter G, Linde A
. Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection. J Clin Microbiol. 1997; 35(11):2728-32.
PMC: 230050.
DOI: 10.1128/jcm.35.11.2728-2732.1997.
View
17.
Womack J, Jimenez M
. Common questions about infectious mononucleosis. Am Fam Physician. 2015; 91(6):372-6.
View
18.
Fleisher G, Collins M, Fager S
. Limitations of available tests for diagnosis of infectious mononucleosis. J Clin Microbiol. 1983; 17(4):619-24.
PMC: 272704.
DOI: 10.1128/jcm.17.4.619-624.1983.
View
19.
Crawford D, Macsween K, Higgins C, Thomas R, McAulay K, Williams H
. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis. 2006; 43(3):276-82.
DOI: 10.1086/505400.
View
20.
Balfour Jr H, Holman C, Hokanson K, Lelonek M, Giesbrecht J, White D
. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis. 2005; 192(9):1505-12.
DOI: 10.1086/491740.
View